A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
J1B-MC-FRCF - ClinicalTrials.gov - NCT04159701
The reason for this study is to see if the study drug LY3454738 is safe and effective as treatment for participants with hives that are caused by chronic spontaneous urticaria (CSU) and that are not controlled with H1-antihistamines.
Trial Summary
Age Range
18 - 65 yearsConditions the trial is for
What the trial is testing?
Could I receive a Placebo?
YesEnrollment Goal
52Trial Dates
Nov 15, 2019 - Feb 24, 2021How long will I be in the trial?
The study will last about 39 weeks and may include up to 18 visits.Trial Phase
IILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo